PT - JOURNAL ARTICLE AU - Steven R. Hwang AU - Adam P. Sawatsky TI - A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab AID - 10.3899/jrheum.190197 DP - 2019 Nov 01 TA - The Journal of Rheumatology PG - jrheum.190197 4099 - http://www.jrheum.org/content/early/2019/10/28/jrheum.190197.short 4100 - http://www.jrheum.org/content/early/2019/10/28/jrheum.190197.full AB - Manifestations of renal disease have been reported to develop after tumor necrosis factor-α (TNF-α) inhibition, and they should be considered as a possible complication as TNF-α inhibitors become more prevalent in the treatment of autoimmune inflammatory diseases. We report a case of minimal change disease (MCD) that developed in a woman receiving the TNF-α inhibitor certolizumab and was resolved with high-dose steroids and discontinuation of TNF-α blockade.